{{Rsnum
|rsid=1264459
|Gene=HLA-E
|Chromosome=6
|position=30488143
|Orientation=minus
|GMAF=0.1437
|Gene_s=HLA-E
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 23.0 | 74.3
| HCB | 0.0 | 10.2 | 89.8
| JPT | 0.0 | 4.4 | 95.6
| YRI | 3.4 | 27.2 | 69.4
| ASW | 5.3 | 29.8 | 64.9
| CHB | 0.0 | 10.2 | 89.8
| CHD | 0.0 | 11.0 | 89.0
| GIH | 3.0 | 13.9 | 83.2
| LWK | 5.5 | 37.3 | 57.3
| MEX | 3.4 | 22.4 | 74.1
| MKK | 0.6 | 22.4 | 76.9
| TSI | 3.9 | 31.4 | 64.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21847675
|Title=Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}